Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal

By Visser B.C.   Venook A.P.   Patti M.G.  

Surgical Oncology, Vol. 12, Iss. 1, 2003-07 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Refining Esophageal Cancer Staging After Neoadjuvant Therapy: Importance of Treatment Response

By Barbour Andrew  

Annals of Surgical Oncology, Vol. 15, Iss. 10, 2008-10 ,pp. : 2894-2902

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Chemoradiation Therapy in Patients with Surgically Treated Esophageal Cancer

By Vermund Halvor   Pories Walter J.   Hillard Jessica   Wiley Albert L.   Youngblood Robert  

Acta Oncologica, Vol. 40, Iss. 5, 2001-09 ,pp. : 558-565

Informa Healthcare

Access to resources Recommend Favorite

Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy

By Okumura Hiroshi  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 329-334

Springer Publishing Company

Access to resources Recommend Favorite

Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients

By                  

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 446-452

Spandidos Publications

Access to resources Recommend Favorite